These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1297640)

  • 21. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils.
    Lancet; 1974 Aug; 2(7875):237-40. PubMed ID: 4135686
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong.
    Chan SL; Wong PC; Tam CM
    Tuber Lung Dis; 1994 Aug; 75(4):245-50. PubMed ID: 7949069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Standardized controlled antitubercular therapy and results in 755 patients].
    Wiesner B; Cramer G; Hamel U; Roth G
    Z Erkr Atmungsorgane; 1991; 177(1-2):71-5. PubMed ID: 1808855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
    Cowie RL; Brink BA
    S Afr Med J; 1990 Apr; 77(8):390-1. PubMed ID: 2184527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Which treatment for primary tuberculosis?].
    Gallet S; Bellon G
    Pediatrie; 1989; 44(9):699-704. PubMed ID: 2695890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
    Mitchison DA; Nunn AJ
    Am Rev Respir Dis; 1986 Mar; 133(3):423-30. PubMed ID: 2420242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 29. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1974 Nov; 2(7889):1100-6. PubMed ID: 4139405
    [No Abstract]   [Full Text] [Related]  

  • 30. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
    Rodrigues Carvalho S; Silva I; Leiria-Pinto P; Rosado-Pinto J
    Allergol Immunopathol (Madr); 2009; 37(6):336-8. PubMed ID: 19875222
    [No Abstract]   [Full Text] [Related]  

  • 32. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
    Rustomjee R; Lienhardt C; Kanyok T; Davies GR; Levin J; Mthiyane T; Reddy C; Sturm AW; Sirgel FA; Allen J; Coleman DJ; Fourie B; Mitchison DA;
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):128-38. PubMed ID: 18230244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ambulatory management of tuberculosis.
    Hampton JR; Bates JH
    Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
    [No Abstract]   [Full Text] [Related]  

  • 34. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
    Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
    Szklo A; Mello FC; Guerra RL; Dorman SE; Muzy-de-Souza GR; Conde MB
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):775-80. PubMed ID: 17609053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Jun; 111(6):845-8 CONTD. PubMed ID: 49163
    [No Abstract]   [Full Text] [Related]  

  • 37. Short course chemotherapy of pulmonary tuberculosis and its possible impact on epidemiology of disease.
    Mehrotra ML; Gautam KD; Chaube CK
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):195-202. PubMed ID: 7166353
    [No Abstract]   [Full Text] [Related]  

  • 38. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 40. [Short-term treatment of pulmonary tuberculosis].
    Karuga WK
    Bull Int Union Tuberc; 1974; 49(1):388-97. PubMed ID: 4143178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.